LifeRx.md Inc. disclosed the personal information of people seeking weight-loss treatments to third parties for advertising purposes in violation of New York’s consumer-protection law, a proposed federal class action said.
Amber Hedgeman alleged that LifeRx.md, a seller of the weight-loss drug GLP-1, disclosed her name, email address, and phone number to
The information allowed the third parties to identify her as someone interested in weight-loss drugs such as Ozempic and other versions ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
